A drug with the SMILES Cc1cc2c(cc1C)N(Cc1ccc(Cl)cc1)C1=NCCCN12 has a human ether-à-go-go related gene (hERG) inhibition at 10uM of -69.763%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
Cc1cc2c(cc1C)N(Cc1ccc(Cl)cc1)C1=NCCCN12
Cc1cc2c(cc1C)N(Cc1ccc(Cl)cc1)C1=NCCCN12
10-[(4-chlorophenyl)methyl]-7,8-dimethyl-3,4-dihydro-2H-pyrimido[1,2-a]benzimidazole